Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ipilimumab
Recurrent Non-Hodgkin Lymphoma
OHSU Knight Cancer InstituteP2BB (68)
Obinutuzumab
MALT Lymphoma
University of WashingtonP2BB (68)
Pembrolizumab
Fallopian Tube Carcinoma
Roswell Park Cancer InstituteP2BB (68)
Pembrolizumab
Primary Mediastinal Large B-Cell Lymphoma
Seda S. ToluP2BB (68)
Relatlimab
Neoplasm
Bristol-Myers SquibbP2BB (68)
Pembrolizumab
Uveal Melanoma
BioInvent International ABP2/3BB (68)
Atezolizumab
Hepatocellular Carcinoma
Icahn School of Medicine at Mount SinaiP4BB (67)
Atezolizumab
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P4BB (67)
Blinatumomab
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP4BB (67)
Cetuximab
Colorectal Cancer
Fudan UniversityP4BB (67)
DARATUMUMAB
Plasma Cell Myeloma
Janssen Research & Development, LLCP4BB (67)
Durvalumab
Durvalumab
Chang Gung Memorial HospitalP4BB (67)
Durvalumab
Non-Small Cell Lung Carcinoma
University of ChicagoP4BB (67)
Evolocumab
Acute Stroke
The Affiliated Hospital of Xuzhou Medical UniversityP4BB (67)
Galcanezumab
Vestibular Migraine
Stanford UniversityP4BB (67)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Breast Neoplasm
Merck Sharp & Dohme LLCP4BB (67)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P4BB (67)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Multiple Sclerosis
Rennes University HospitalP4BB (67)
Ipilimumab
Renal Cell Carcinoma
SWOG Cancer Research NetworkP4BB (67)
Nivolumab
Non-small Cell Lung Cancer
University of ChicagoP4BB (67)
Pembrolizumab
Renal Cell Carcinoma
City of Hope Medical CenterP4BB (67)
TRASTUZUMAB
Breast Cancer
SWOG Cancer Research NetworkP4BB (67)
Blinatumomab
Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (67)
Blinatumomab
Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (67)
Blinatumomab
Childhood Leukemia, Acute Lymphoblastic
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (67)
Showing 176 to 200 of 6,371 assets
PreviousPage 8 of 255Next